Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Boor Kathryn Jean
Director at Sarepta Therapeutics. Filing since 11 Mar 2024.
CIK 0001761826
Company
Date
Role
Action
Shares
Amount
Of holding
SRPT
Sarepta Therapeutics, Inc.
5 Dec 2024
Director
Sold at will
1,636
$205.40K
21.8%
SRPT
Sarepta Therapeutics, Inc.
11 Mar 2024
Director
Sold at will
761
$93.55K
9.2%
2 decisions on file.